John Bender Joins Woodstock Sterile Solutions, Halo Pharma as VP, Business Development

Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), and Halo Pharma, a leading CDMO specializing in pharmaceutical services, have named John Bender as the new Vice President of Business Development for the two organizations.

Bender is a 35-year veteran of the pharmaceutical industry and brings deep expertise in CDMO services to his new role. He joins the organization from Alvogen Pharmaceuticals, where he most recently served as Vice President of U.S. Third Party Operations, overseeing CDMO strategic sourcing for North America. Prior to that, he was Vice President of Business Development for Alvogen’s Norwich Pharma CDMO Services division.

“John’s extensive experience in the CDMO sector—not only in sales but also as a buyer of CDMO services—along with his proven track record of building long-term partnerships comes at a great time as we look to launch sterile filling services out of Halo and grow our blow-fill-seal business as we expand our bottle packaging operations at Woodstock,” said Lee Karras, Executive Chairman.

John will be based in Illinois and lead sales and marketing efforts across Woodstock Sterile Solutions and Halo Pharma, focusing on expanding client partnerships and driving growth for the two CDMO businesses.

“Spending the last seven years ‘on the customer side’ provided me with invaluable perspective on what makes CDMOs truly exceptional—from business development and customer service to operational delivery,” said Bender. “I look forward to bringing those insights to our team and to help shape a proactive, customer-centric business development approach that builds a strong pipeline and lasting partnerships.”

For more information about Woodstock Sterile Solutions, visit https://woodstocksterilesolutions.com and for information on Halo Pharma, visit https://halopharma.com.

About Halo Pharma
Halo Pharma is a rapidly growing contract development and manufacturing organization (CDMO) that provides scientific and development expertise, as well as a wide spectrum of manufacturing services, from its locations in Whippany, New Jersey, USA and Montreal, Quebec, Canada to its international client base. Halo offers fully integrated capabilities in a variety of dosage forms including tablets, capsules, powders, liquids, creams, sterile and non-sterile ointments and suppositories. The company is registered to work with any of these dosages in the CI-CV DEA designations. Halo Pharma’s capabilities in the areas of tech transfer, process and product development, production, scale-up/validation and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. For more information, please contact services@halopharma.com.

About Woodstock Sterile Solutions
For more than 55 years, Woodstock Sterile Solutions has been recognized as a leading Blow-Fill-Seal (BFS) Contract Development and Manufacturing Organization (CDMO). We develop and supply BFS products for pharmaceutical and healthcare companies, providing best-in-class sterile development manufacturing solutions across a broad – and growing – range of applications, including diagnostic, respiratory, ophthalmic, topical, otic, and oral. As a highly focused organization, our expertise and commitment to innovation allow us to reduce development times and efficiently support our customers’ ability to deliver products to market. At Woodstock Sterile Solutions, we see a patient, family member or friend in every product we make, and our goal is to be the best development and commercial partner in the industry, delivering life-enhancing molecules from the benchtop to the patient. 

Media Contact
Resource Advantage
Dan Green
dgreen@resourceadvantage.com

Company Contact
Woodstock Sterile Solutions
Stacy London
Stacy.london@wssterile.com